![Daniela Marino, CUTISS 🇨🇠| Tissue Engineering, Skin Grafts | E42 [Sponsored]](https://flot.bio/wp-content/uploads/2025/10/Website-Thumbnail-Daniela-Marino-1080x648.avif)
Daniela Marino, CUTISS 🇨🇠| Tissue Engineering, Skin Grafts | E42 [Sponsored]
Hot on the heels of CUTISS’ $60M Series C round, we catch up once more...
•
Dragan Grabulovski, Araris 🇨🇠| ADC Linkers, Replacing Chemotherapy | E41
Philip meets up with Dragan Grabulovski, CEO of the startup Araris, at Lake Zurich to...
•
Stefano Portolano, Azafaros 🇳🇱 🇨🇠| Rare Diseases, Small Molecules | E40
On a trip to Basel, Switzerland, Philip catches up with Stefano Portolano, CEO of the...
•
Alex Zhavoronkov, Insilico Medicine | AI Drug Development, Longevity | E39
We chat about longevity with Alex Zhavoronkov, CEO and founder of the artificial intelligence (AI)...
•
Robin Carr, Myricx Bio 🇬🇧 | New ADC Payloads, London Biotech Startups | E38
We jet off to Central London to meet Robin Carr, CEO of Myricx Bio, a...
Why ADCs and Radiopharmaceuticals Are Big Pharma’s New Obsession
Antibody-drug conjugates (ADCs) and radiopharmaceuticals have moved from the fringes of biotech buzzwords into the...
Baker Brothers Investing Secrets: Lessons from One of Biotech’s Most Successful and Private Backers
In a biotech landscape dominated by hype and volatility, the Baker Brothers have emerged as...
![Aino Kalervo, TILT Biotherapeutics 🇫🇮 | Immunotherapy, Oncolytic Virus | E37 [Sponsored]](https://flot.bio/wp-content/uploads/2025/07/Website-Thumbnail-Aino-Kalervo-1080x648.avif)
Aino Kalervo, TILT Biotherapeutics 🇫🇮 | Immunotherapy, Oncolytic Virus | E37 [Sponsored]
We dive into the world of cutting-edge cancer treatments with Aino Kalervo, Chief Operating Officer...
•
Renee Aguiar-Lucander, Hansa Biopharma 🇸🇪 | Immunology, Gene therapy | E36
Fresh after leading Calliditas Therapeutics through a $1.1B acquisition, Renee Aguiar-Lucander takes us through her...
•
Stephane Bancel, Moderna | mRNA Therapeutics, Boston Biotech Mafia, AI Biotech | E35
We’re with Stephane Bancel, CEO of the US mRNA giant Moderna. The company’s 15-year trajectory has...
•
Never Miss a New Episode đź’Ś
Trusted by 2500+ biopharma professionals from top companies like argenx, Roche, and Forbion. No spam, no noise.
Watch & Subscribe
